CCP
GWPH

Clough Capital Partners’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Clough Capital Partners’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-91,486
Closed -$10.6M – 178
2020
Q4 		$10.6M Sell
91,486
-99,230
-52% -$11.1M 0.75% 50
2020
Q3 		$18.6M Buy
190,716
+89,970
+89% +$10.4M 1.34% 28
2020
Q2 		$12.4M Sell
100,746
-2,600
-3% -$295K 1.21% 28
2020
Q1 		$9.05M Sell
103,346
-26,690
-21% -$2.83M 0.9% 33
2019
Q4 		$13.6M Buy
130,036
+75,149
+137% +$8.43M 1.16% 31
2019
Q3 		$6.31M Sell
54,887
-15,220
-22% -$2.31M 0.52% 46
2019
Q2 		$12.1M Buy
70,107
+23,500
+50% +$4.06M 1.19% 29
2019
Q1 		$7.86M Sell
46,607
-21,610
-32% -$3.22M 0.69% 48
2018
Q4 		$6.64M Buy
68,217
+28,226
+71% +$3.7M 0.78% 51
2018
Q3 		$6.91M Sell
39,991
-11,400
-22% -$1.64M 0.65% 54
2018
Q2 		$7.17M Sell
51,391
-26,300
-34% -$3.74M 0.64% 50
2018
Q1 		$8.75M Buy
77,691
+4,820
+7% +$606K 0.84% 46
2017
Q4 		$9.62M Sell
72,871
-13,100
-15% -$1.54M 0.8% 45
2017
Q3 		$8.72M Buy
85,971
+38,000
+79% +$4.07M 0.58% 52
2017
Q2 		$4.81M Sell
47,971
-50,229
-51% -$5.41M 0.33% 69
2017
Q1 		$11.9M Buy
98,200
+50,900
+108% +$6.24M 0.75% 41
2016
Q4 		$5.29M Buy
47,300
+11,600
+32% +$1.4M 0.35% 78
2016
Q3 		$4.74M Buy
35,700
+32,000
+865% +$3.06M 0.25% 101
2016
Q2 		$339K Buy
+3,700
New +$311K 0.02% 166
2016
Q1 		– Sell
-220,276
Closed -$15.3M – 256
2015
Q4 		$15.3M Buy
220,276
+27,249
+14% +$2.22M 0.72% 49
2015
Q3 		$17.6M Sell
193,027
-13,053
-6% -$1.45M 0.76% 46
2015
Q2 		$25.3M Sell
206,080
-26,120
-11% -$2.96M 0.97% 31
2015
Q1 		$21.2M Buy
232,200
+147,600
+174% +$12M 0.7% 58
2014
Q4 		$5.73M Sell
84,600
-108,000
-56% -$7.89M 0.21% 117
2014
Q3 		$15.6M Buy
+192,600
New +$17M 0.58% 62

Other funds holding GWPH

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Clough Capital Partners's GWPH Position: Q1 2021 in Review

Clough Capital Partners sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2021, closing a stake of 91,486 shares — an estimated $10.6M sold.

Clough Capital Partners first reported a position in GWPH in Q3 2014 and held it in 25 quarters. The position peaked at $25.3M in Q2 2015. 297 funds tracked by Wall St. Rank hold GWPH as of Q1 2021.

  • Clough Capital Partners reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2021 after selling out during the quarter.
  • Clough Capital Partners sold 91,486 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2021, an estimated $10.6M.
  • Clough Capital Partners first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2014 and held it in 25 quarters.
  • Clough Capital Partners's GW Pharmaceuticals Plc American Depositary Shares position peaked at $25.3M in Q2 2015.
  • 297 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2021.

Based on Clough Capital Partners's 13F filing for Q1 2021, filed 17 May 2021.